PDP Couriers achieves WDA Licence

PDP Couriers, the leader in clinical trial drug distribution and biological sample transportation has achieved its Wholesale Distribution Authorization (WDA) licence, awarded by the UK Medicines and Healthcare Products Regulatory Agency (MHRA).

This content was submitted directly to this website by the supplier.

Achieving its WDA licence, PDP Couriers continues to focus on delivering value added services for its customers. Susan Lewis, Global Quality Manager & Responsible Person explained: "A WDA shows our customers that we take Good Distribution Practice seriously and provides assurance that products are safe and secure because they stay in one supply chain.

"Initial feedback from our customers has been really positive and as a company we are ready to embark on new challenges within the pharmaceutical industry."

A WDA is a requirement for any company in the UK that procures, stores or supplies medicines. Confirming that PDP's offering provides secure, temperature-controlled premises for the storage of medicines and has developed a set of Standard Operating Procedures (SOPs) that comply with Good Distribution Practice (GDP) guidelines.

The added benefit of being able to offer storage of customer's products in a compliant environment is yet another contingency measure that the company can call upon should there be regulatory or transportation issues at origin or destination.

As counterfeiting is an issue worldwide the WDA also provides PDP's customers with added peace of mind as they know their product never leaves the supply chain and therefore cannot be compromised.

The WDA has been the culmination of a yearlong project, which was put in place to ensure PDP is continuing to develop its customer offering. This further reassures customers that PDP is continuing to maintain its already high level of Good Distribution Practice with the safety of patients always uppermost in the minds of its employees.

Companies in this article
More in Home